Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KD Pharma is a leading contract development and manufacturing organization (CDMO) specializing in the production of high-purity Omega-3 fatty acids for the pharmaceutical and nutraceutical industries. Headquartered in Bexbach, Germany, the company utilizes its proprietary KD-Pür technology, which employs supercritical fluid extraction and chromatography to achieve exceptional purity levels of EPA and DHA. KD Pharma provides a comprehensive range of services from API development to finished dosage form manufacturing, including softgel encapsulation. The company serves global markets, focusing on therapeutic areas such as cardiovascular health, cognitive function, and inflammatory disorders. As a key player in the lipid space, KD Pharma offers customized solutions for complex lipid-based drug delivery and active ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on K.D. Pharma Bexbach.